Oral Antidiabetic (OAD) Treatment Market Report

Global and Region Oral Antidiabetic (OAD) Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：227
  • REPORT CODE：GMM950401
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Oral Antidiabetic (OAD) Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Oral Antidiabetic (OAD) Treatmentmarket, defines the market attractiveness level of Oral Antidiabetic (OAD) Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Oral Antidiabetic (OAD) Treatment industry, describes the types of Oral Antidiabetic (OAD) Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Oral Antidiabetic (OAD) Treatment market and the development prospects and opportunities of Oral Antidiabetic (OAD) Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Oral Antidiabetic (OAD) Treatment market in Chapter 13.

    By Player:

    • Novartis

    • AstraZeneca

    • Merck

    • Mannkind

    • Eli Lilly

    • Pfizer

    • Boehringer Ingelheim

    • Glenmark

    • Sanofi

    • Novo Nordisk

    By Type:

    • Sulphonylureas

    • Biguanides

    • Intestinal -Glucosidase Inhibitors

    • Others

    By End-User:

    • Hospital

    • Clinics

    • Diabetics Treatment Centres

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Oral Antidiabetic (OAD) Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Oral Antidiabetic (OAD) Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Oral Antidiabetic (OAD) Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Oral Antidiabetic (OAD) Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Oral Antidiabetic (OAD) Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Oral Antidiabetic (OAD) Treatment Consumption (2017-2022)

    • 7.2 United States Oral Antidiabetic (OAD) Treatment Consumption (2017-2022)

    • 7.3 Europe Oral Antidiabetic (OAD) Treatment Consumption (2017-2022)

    • 7.4 China Oral Antidiabetic (OAD) Treatment Consumption (2017-2022)

    • 7.5 Japan Oral Antidiabetic (OAD) Treatment Consumption (2017-2022)

    • 7.6 India Oral Antidiabetic (OAD) Treatment Consumption (2017-2022)

    • 7.7 South Korea Oral Antidiabetic (OAD) Treatment Consumption (2017-2022)

    8 Region and Country-wise Oral Antidiabetic (OAD) Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Oral Antidiabetic (OAD) Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Oral Antidiabetic (OAD) Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Oral Antidiabetic (OAD) Treatment Consumption Forecast (2022-2028)

    • 8.4 China Oral Antidiabetic (OAD) Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Oral Antidiabetic (OAD) Treatment Consumption Forecast (2022-2028)

    • 8.6 India Oral Antidiabetic (OAD) Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Oral Antidiabetic (OAD) Treatment Consumption Forecast (2022-2028)

    9 Global Oral Antidiabetic (OAD) Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Oral Antidiabetic (OAD) Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Sulphonylureas Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Biguanides Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Intestinal -Glucosidase Inhibitors Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Oral Antidiabetic (OAD) Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Diabetics Treatment Centres Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Oral Antidiabetic (OAD) Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Oral Antidiabetic (OAD) Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Sulphonylureas Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Biguanides Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Intestinal -Glucosidase Inhibitors Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Oral Antidiabetic (OAD) Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Diabetics Treatment Centres Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Oral Antidiabetic (OAD) Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Oral Antidiabetic (OAD) Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Oral Antidiabetic (OAD) Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Oral Antidiabetic (OAD) Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Oral Antidiabetic (OAD) Treatment Market Competitive Analysis

    • 14.1 Novartis

      • 14.1.1 Novartis Company Details

      • 14.1.2 Novartis Oral Antidiabetic (OAD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Novartis Oral Antidiabetic (OAD) Treatment Product and Service

    • 14.2 AstraZeneca

      • 14.2.1 AstraZeneca Company Details

      • 14.2.2 AstraZeneca Oral Antidiabetic (OAD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 AstraZeneca Oral Antidiabetic (OAD) Treatment Product and Service

    • 14.3 Merck

      • 14.3.1 Merck Company Details

      • 14.3.2 Merck Oral Antidiabetic (OAD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Merck Oral Antidiabetic (OAD) Treatment Product and Service

    • 14.4 Mannkind

      • 14.4.1 Mannkind Company Details

      • 14.4.2 Mannkind Oral Antidiabetic (OAD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Mannkind Oral Antidiabetic (OAD) Treatment Product and Service

    • 14.5 Eli Lilly

      • 14.5.1 Eli Lilly Company Details

      • 14.5.2 Eli Lilly Oral Antidiabetic (OAD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Eli Lilly Oral Antidiabetic (OAD) Treatment Product and Service

    • 14.6 Pfizer

      • 14.6.1 Pfizer Company Details

      • 14.6.2 Pfizer Oral Antidiabetic (OAD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Pfizer Oral Antidiabetic (OAD) Treatment Product and Service

    • 14.7 Boehringer Ingelheim

      • 14.7.1 Boehringer Ingelheim Company Details

      • 14.7.2 Boehringer Ingelheim Oral Antidiabetic (OAD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Boehringer Ingelheim Oral Antidiabetic (OAD) Treatment Product and Service

    • 14.8 Glenmark

      • 14.8.1 Glenmark Company Details

      • 14.8.2 Glenmark Oral Antidiabetic (OAD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Glenmark Oral Antidiabetic (OAD) Treatment Product and Service

    • 14.9 Sanofi

      • 14.9.1 Sanofi Company Details

      • 14.9.2 Sanofi Oral Antidiabetic (OAD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Sanofi Oral Antidiabetic (OAD) Treatment Product and Service

    • 14.10 Novo Nordisk

      • 14.10.1 Novo Nordisk Company Details

      • 14.10.2 Novo Nordisk Oral Antidiabetic (OAD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Novo Nordisk Oral Antidiabetic (OAD) Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Oral Antidiabetic (OAD) Treatment

    • Figure Oral Antidiabetic (OAD) Treatment Picture

    • Table Global Oral Antidiabetic (OAD) Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Oral Antidiabetic (OAD) Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Oral Antidiabetic (OAD) Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Oral Antidiabetic (OAD) Treatment Consumption by Country (2017-2022)

    • Figure United States Oral Antidiabetic (OAD) Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Oral Antidiabetic (OAD) Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Oral Antidiabetic (OAD) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Oral Antidiabetic (OAD) Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Oral Antidiabetic (OAD) Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Oral Antidiabetic (OAD) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Oral Antidiabetic (OAD) Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Oral Antidiabetic (OAD) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Oral Antidiabetic (OAD) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Oral Antidiabetic (OAD) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Oral Antidiabetic (OAD) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Oral Antidiabetic (OAD) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Oral Antidiabetic (OAD) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Sulphonylureas Consumption and Growth Rate (2017-2022)

    • Figure Global Biguanides Consumption and Growth Rate (2017-2022)

    • Figure Global Intestinal -Glucosidase Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Diabetics Treatment Centres Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Sulphonylureas Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biguanides Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Intestinal -Glucosidase Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diabetics Treatment Centres Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Oral Antidiabetic (OAD) Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Oral Antidiabetic (OAD) Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Oral Antidiabetic (OAD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Oral Antidiabetic (OAD) Treatment Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Oral Antidiabetic (OAD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Oral Antidiabetic (OAD) Treatment Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Oral Antidiabetic (OAD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Oral Antidiabetic (OAD) Treatment Product and Service

    • Table Mannkind (Foundation Year, Company Profile and etc.)

    • Table Mannkind Oral Antidiabetic (OAD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mannkind Oral Antidiabetic (OAD) Treatment Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Oral Antidiabetic (OAD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Oral Antidiabetic (OAD) Treatment Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Oral Antidiabetic (OAD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Oral Antidiabetic (OAD) Treatment Product and Service

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Oral Antidiabetic (OAD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Oral Antidiabetic (OAD) Treatment Product and Service

    • Table Glenmark (Foundation Year, Company Profile and etc.)

    • Table Glenmark Oral Antidiabetic (OAD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Glenmark Oral Antidiabetic (OAD) Treatment Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Oral Antidiabetic (OAD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Oral Antidiabetic (OAD) Treatment Product and Service

    • Table Novo Nordisk (Foundation Year, Company Profile and etc.)

    • Table Novo Nordisk Oral Antidiabetic (OAD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk Oral Antidiabetic (OAD) Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US